SCHEMBL989637

SCHEMBL989637

O=CCCNC(=O)C(F)(F)F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA3 P07451 2/20 0.63
CA5A P35218 2/20 0.63
CA5B Q9Y2D0 2/20 0.63
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
POLB P06746 1/20 0.60
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
CA2 P00918 2/20 0.57
CA14 Q9ULX7 2/20 0.57
CA12 O43570 1/20 0.57
CA4 P22748 1/20 0.57
CA6 P23280 1/20 0.57
CA7 P43166 1/20 0.57
CA9 Q16790 1/20 0.57
EPHX1 P07099 1/20 0.48
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
ALOX12 P18054 1/20 0.36
PGK1 P00558 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6975512 0.87 ALDH1A1 (0.68) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL13861685 0.85 ALDH1A1 (0.79) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL12116359 0.84 ALDH1A1 (0.64) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL9557113 0.84 MEN1 (0.73) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL1252712 0.83 CA3 (0.86) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL10231803 0.83 CA3 (0.86) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL9430552 0.80 ALDH1A1 (0.58) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL6941681 0.79 ALDH1A1 (0.42) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL2845918 0.77 POLB (0.42) CA3CA5ACA5BALDH1A1SMN1; SMN2
SCHEMBL19549140 0.77 ALDH1A1 (0.54) CA3CA5ACA5BALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260002939-A1 METHODS AND SYSTEMS FOR SENSITIVE AND MULTIPLEXED ANALYSIS OF BIOLOGICAL SAMPLES USING CLEAVABLE FLUORPHORES AND CLICK CHEMISTRY UNIV ARIZONA STATE (US) 2026-01-01 US disclosed
WO-2024263272-A2 METHODS AND SYSTEMS FOR SENSITIVE AND MULTIPLEXED ANALYSIS OF BIOLOGICAL SAMPLES USING CLEAVABLE FLUORPHORES AND 'CLICK' CHEMISTRY ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-12-26 WO disclosed
EP-3976185-B1 HECT E3 LIGASE INHIBITORS AND USES THEREOF IFOM ST FONDAZIONE DI ONCOLOGIA MOLECOLARE ETS (IT) 2024-02-14 EP disclosed
CN-107434803-B Inhibitors of histone demethylases 吉利德科学公司 2020-05-05 CN disclosed
US-10221139-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-03-05 US disclosed
US-10189787-B2 Inhibitors of histone demethylases GILEAD SCIENCES, INC. (US) 2019-01-29 US disclosed
EP-3023415-B1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES INC (US) 2017-12-06 EP disclosed
CN-107434803-A Histone demethylase inhibitor 吉利德科学公司 2017-12-05 CN disclosed
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2017-11-09 US disclosed
CN-104981458-B Inhibitors of histone demethylases 吉利德科学公司 2017-07-21 CN disclosed
US-9422232-B2 Reductive release probes containing a chemoselectively cleavable α-azidoether linker and methods of use thereof THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2016-08-23 US disclosed
EP-3023415-A1 INHIBITORS OF HISTONE DEMETHYLASES Epitherapeutics ApS (DK) 2016-05-25 EP disclosed
CN-104981458-A Inhibitors of histone demethylases EPITHERAPEUTICS APS 2015-10-14 CN disclosed
EP-2903968-A1 INHIBITORS OF HISTONE DEMETHYLASES Epitherapeutics ApS (DK) 2015-08-12 EP disclosed
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2015-07-23 US disclosed
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES GILEAD SCIENCES, INC. 2014-12-18 US disclosed
WO-2014053491-A1 INHIBITORS OF HISTONE DEMETHYLASES EPITHERAPEUTICS APS (DK) 2014-04-10 WO disclosed
US-20120178086-A1 REDUCTIVE RELEASE PROBES CONTAINING A CHEMOSELECTIVELY CLEAVABLE ALPHA-AZIDOETHER LINKER AND METHODS OF USE THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2012-07-12 US disclosed
US-20120178086-A1 REDUCTIVE RELEASE PROBES CONTAINING A CHEMOSELECTIVELY CLEAVABLE ALPHA-AZIDOETHER LINKER AND METHODS OF USE THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2012-07-12 US disclosed
WO-2011005821-A1 REDUCTIVE RELEASE PROBES CONTAINING A CHEMOSELECTIVELY CLEAVABLE ALPHA-AZIDOETHER LINKER AND METHODS OF USE THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2011-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189787-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 CA3 3669/4885CA5A 1893/4885CA5B 2754/4885
US-20260002939-A1 METHODS AND SYSTEMS FOR SENSITIVE AND MULTIPLEXED ANALYSIS OF BIOLOGICAL SAMPLES USING CLEAVABLE FLUORPHORES AND CLICK CHEMISTRY TYRO3, SRMS, CTSZ CA3 627/4885CA5A 2028/4885CA5B 2496/4885
US-20150203453-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 CA3 3575/4885CA5A 1745/4885CA5B 2618/4885
US-20140371195-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 CA3 3669/4885CA5A 1893/4885CA5B 2754/4885
US-20170320827-A1 INHIBITORS OF HISTONE DEMETHYLASES EHMT1, KDM1B, EHMT2 CA3 3669/4885CA5A 1893/4885CA5B 2754/4885
US-10221139-B2 Inhibitors of histone demethylases EHMT1, KDM1B, EHMT2 CA3 3669/4885CA5A 1893/4885CA5B 2754/4885
US-20120178086-A1 REDUCTIVE RELEASE PROBES CONTAINING A CHEMOSELECTIVELY CLEAVABLE ALPHA-AZIDOETHER LINKER AND METHODS OF USE THEREOF CPSF1, CPSF7, CPSF6 CA3 1771/4885CA5A 4270/4885CA5B 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.